From chemotherapy to CAR T-cell therapy, treatments for hematology and oncology have advanced dramatically, especially in recent years. As new, revolutionary oncology treatments come about, the importance of rigorous reviews and oversight becomes even more critical.

In this webinar, “Oncology Breakthroughs: Emerging Trends and Pioneering Research,” our expert panelists delve into the latest developments in oncology treatments and research, the role of biosafety and Institutional Biosafety Committee (IBC) oversight, Institutional Review Board (IRB) considerations in pioneering research, and WCG’s IBC and IRB impact on revolutionary treatments.

Key Topics:

• Innovative Advancements: Discover the latest treatments for hematology/oncology and their potential to revolutionize clinical outcomes.
• Biosafety Oversight: Gain insights into the complexities of IBC reviews and the steps involved in mitigating risks.
• Ethical Considerations: Understand the areas of consideration for IRB when reviewing cutting edge oncology research.

At the conclusion of these key topics, our panelists answered live questions from the audience. Watch the recording now to learn more about the emerging oncology treatments and the impact of ethical and biosafety reviews.